Brineura Active Ingredient(s): Cerliponase Alfa FDA Approved: * April 27, 2017Pharm Company: * BIOMARIN PHARM Category: Neurological Disorders * This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Recent Brineura Forums:
Be the first to
start a discussion about this drug.
Possible Dosages for this and Related Drugs:
Cerliponase Alfa
Note: Above list includes dosages for all drugs with the same combination of active ingredients.
NDC Database Records for Brineura: (1 result)
Sorted by National Drug Code
68135-811 Brineura Intraventricular Kit by Biomarin Pharmaceutical Inc.
Other drugs which contain Cerliponase Alfa or a similar ingredient: (1 result)
Note: All times displayed are GMT - 7. This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer . This page was last updated on 15 June 2021. We are committed to your privacy. Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA
